Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nea Pitulis"'
Publikováno v:
Expert Opinion on Therapeutic Targets. 11:1071-1085
Peroxisome proliferator activated receptors (PPARs) are members of the nuclear receptor superfamily acting as transcription factors. PPAR-gamma, one of the three PPAR subtypes, is expressed in many malignant and non-malignant cells and tissues. PPAR-
Autor:
Nea Pitulis, Theodoros Dimopoulos, Haralampos Katopodis, Dimitrios Karamanolakis, Michael Koutsilieris, Antonis Halapas, John Bogdanos, N Pissimissis, Effie Papageorgiou, Peter Dimopoulos, Antigone Sourla, Constantine Milathianakis, Peter Lembessis, Roxane Tenta
Publikováno v:
Expert Opinion on Investigational Drugs. 15:795-804
The development of resistance to anticancer therapies is a major hurdle in preventing long-lasting clinical responses to conventional therapies in hormone-refractory prostate cancer. Herein, the molecular evidence documenting that bone metastasis mic
Autor:
Nea, Pitulis, Efstathia, Papageorgiou, Roxane, Tenta, Peter, Lembessis, Michael, Koutsilieris
Publikováno v:
Anticancer research. 29(6)
Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and interleukin (IL)-6 are key factors for controlling prostate cancer cell proliferation and survival.Herein we used the natural PPARgamma ligand, 15deoxy Delta12-14 PGJ(2) (15dPGJ
Autor:
Roxane Tenta, Michael Koutsilieris, Christos Consoulas, Despina Tiblalexi, Haralampos Katopodis, Michael N. Alexis, E Konstantinidou, Nea Pitulis, Menelaos N. Manoussakis, Dimitris Kletsas, A Poyatzi
Publikováno v:
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 40(11)
The aim of our study was to analyze the action of zoledronic acid on MG-63 human osteosarcoma cells. The proliferation of MG-63 cells was inhibited by either continuous or pulsatile exposures of zoledronic acid in a dose-dependent manner (10-250 micr
Autor:
Peter Lembessis, Efstathia Papageorgiou, Nea Pitulis, Menelaos N. Manoussakis, Michael Koutsilieris
PPARgamma, a member of the peroxisome proliferator-activated receptor family, is overexpressed in prostate cancer. Natural and synthetic ligands of PPARgamma via genomic and nongenomic actions promote cell cycle arrest and apoptosis of several prosta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6fbc6cfe6fca3762e2927095aa5bb20
https://europepmc.org/articles/PMC2359675/
https://europepmc.org/articles/PMC2359675/